A detailed history of Curat Global, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Curat Global, LLC holds 3,830 shares of NVO stock, worth $185,601. This represents 0.2% of its overall portfolio holdings.

Number of Shares
3,830
Previous 3,830 -0.0%
Holding current value
$185,601
Previous $264 Million 19.6%
% of portfolio
0.2%
Previous 0.25%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 11, 2025

BUY
$69.3 - $90.95 $265,419 - $348,338
3,830 New
3,830 $266 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $109B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Curat Global, LLC Portfolio

Follow Curat Global, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Curat Global, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Curat Global, LLC with notifications on news.